Gordon Alton

4.5k total citations · 2 hit papers
42 papers, 2.8k citations indexed

About

Gordon Alton is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Gordon Alton has authored 42 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Gordon Alton's work include Glycosylation and Glycoproteins Research (12 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Gordon Alton is often cited by papers focused on Glycosylation and Glycoproteins Research (12 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Gordon Alton collaborates with scholars based in United States, Canada and United Kingdom. Gordon Alton's co-authors include James G. Christensen, Helen Y. Zou, Barbara Mroczkowski, Qiuhua Li, Shinji Yamazaki, Joseph H. Lee, Scott R. McDonnell, Gerrit Los, Maria E. Arango and Mahnaz Razandi and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Molecular and Cellular Biology.

In The Last Decade

Gordon Alton

41 papers receiving 2.7k citations

Hit Papers

An Orally Available Small-Molecule Inhibitor of c-Met, PF... 2007 2026 2013 2019 2007 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms
    2007 593 citations Helen Y. Zou, Qiuhua Li et al. Cancer Research profile →
  2. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
    2007 513 citations James G. Christensen, Helen Y. Zou et al. Molecular Cancer Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon Alton United States 18 1.8k 739 646 390 293 42 2.8k
Richard Kendall United States 24 1.8k 1.0× 837 1.1× 268 0.4× 315 0.8× 153 0.5× 43 3.0k
Jenny Tan United States 20 1.3k 0.7× 648 0.9× 505 0.8× 544 1.4× 82 0.3× 46 2.5k
Liguang Lou China 36 1.9k 1.1× 1.5k 2.1× 613 0.9× 697 1.8× 110 0.4× 135 4.0k
Stephen Gately United States 24 2.0k 1.1× 675 0.9× 343 0.5× 373 1.0× 322 1.1× 40 3.5k
Giuliana Cassinelli Italy 32 1.4k 0.8× 1.0k 1.4× 425 0.7× 260 0.7× 97 0.3× 64 2.5k
Stefan Hart Singapore 23 1.4k 0.8× 1.0k 1.4× 273 0.4× 137 0.4× 104 0.4× 30 2.7k
Akiko Kokubu Japan 25 2.2k 1.2× 649 0.9× 404 0.6× 121 0.3× 122 0.4× 29 3.0k
Stephen Hiscox United Kingdom 36 2.1k 1.2× 1.4k 2.0× 353 0.5× 104 0.3× 472 1.6× 93 3.8k
Saijun Fan United States 21 2.3k 1.3× 1.8k 2.5× 183 0.3× 181 0.5× 254 0.9× 41 3.4k
Sabina Cosulich United Kingdom 26 2.0k 1.1× 526 0.7× 290 0.4× 158 0.4× 115 0.4× 55 2.6k

Countries citing papers authored by Gordon Alton

Since Specialization
Citations

This map shows the geographic impact of Gordon Alton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Alton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Alton more than expected).

Fields of papers citing papers by Gordon Alton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Alton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Alton. The network helps show where Gordon Alton may publish in the future.

Co-authorship network of co-authors of Gordon Alton

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Alton. A scholar is included among the top collaborators of Gordon Alton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Alton. Gordon Alton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, M. Catherine, Qiyue Hu, Laura Lingardo, et al.. (2011). Novel isoquinolone PDK1 inhibitors discovered through fragment-based lead discovery. Journal of Computer-Aided Molecular Design. 25(7). 689–698. 15 indexed citations
2.
Ye, Ping, Cyrille Kuhn, Rahul Sharma, et al.. (2010). Potent and selective thiophene urea-templated inhibitors of S6K. Bioorganic & Medicinal Chemistry Letters. 21(2). 849–852. 12 indexed citations
3.
Hirakawa, Brad, William R. Scott, G. Jayarama Bhat, et al.. (2010). Antisense Inhibition of S6 Kinase 1 Produces Improved Glucose Tolerance and Is Well Tolerated for 4 Weeks of Treatment in Rats. Pharmacology. 87(1-2). 11–23. 6 indexed citations
4.
Li, Hui, Seiji Nukui, Jihong Lou, et al.. (2010). Identification of novel pyrrolopyrazoles as protein kinase C β II inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 584–587. 11 indexed citations
5.
Alton, Gordon & Elizabeth A. Lunney. (2008). Targeting the unactivated conformations of protein kinases for small molecule drug discovery. Expert Opinion on Drug Discovery. 3(6). 595–605. 25 indexed citations
6.
Zou, Helen Y., Qiuhua Li, Joseph H. Lee, et al.. (2007). An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms. Cancer Research. 67(9). 4408–4417. 593 indexed citations breakdown →
7.
Christensen, James G., Helen Y. Zou, Maria E. Arango, et al.. (2007). Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Molecular Cancer Therapeutics. 6(12). 3314–3322. 513 indexed citations breakdown →
8.
Zhu, Jeff, et al.. (2007). Assay optimization and kinetic profile of the human and the rabbit isoforms of 11β-HSD1. Biochemical and Biophysical Research Communications. 357(2). 561–566. 10 indexed citations
9.
Westwick, John, et al.. (2002). Therapeutic modulation of inflammatory gene transcription by kinase inhibitors. Expert Opinion on Biological Therapy. 2(6). 621–632. 8 indexed citations
10.
Alton, Gordon, Adrienne D. Cox, L. Gerard Toussaint, & John Westwick. (2001). Functional proteomics analysis of GTPase signaling networks. Methods in enzymology on CD-ROM/Methods in enzymology. 332. 300–316. 1 indexed citations
11.
Alton, Gordon. (1998). Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 8(3). 285–295. 107 indexed citations
12.
Alton, Gordon, et al.. (1997). Oral Ingestion of Mannose Elevates Blood Mannose Levels: A First Step toward a Potential Therapy for Carbohydrate-Deficient Glycoprotein Syndrome Type I. Biochemical and Molecular Medicine. 60(2). 127–133. 77 indexed citations
13.
Palcic, Monica M., Christine H. Scaman, & Gordon Alton. (1995). Chapter 4 Stereochemistry and cofactor identity status of semicarbazide-sensitive amine oxidases. Progress in brain research. 106. 41–47. 2 indexed citations
14.
Alton, Gordon, et al.. (1995). Stereochemistry of Benzylamine Oxidation by Copper Amine Oxidases. Archives of Biochemistry and Biophysics. 316(1). 353–361. 10 indexed citations
15.
Alton, Gordon, et al.. (1994). Use of N-acetylglucosamiyltransferases I and II in the synthesis of a dideoxypentasaccharide. Bioorganic & Medicinal Chemistry. 2(7). 675–680. 6 indexed citations
16.
Nikrad, Pandurang V., Mohammed A. Kashem, Kenneth B. Wlasichuk, Gordon Alton, & André Venot. (1993). Use of human-milk fucosyltransferase in the chemoenzymic synthesis of analogues of the sialyl Lewis and sialyl Lewis tetrasaccharides modified at the C-2 position of the reducing unit. Carbohydrate Research. 250(1). 145–160. 24 indexed citations
17.
18.
19.
Crawley, Suzanne, Ole Hindsgaul, Gordon Alton, Michael Pierce, & Monica M. Palcic. (1990). An enzyme-linked immunosorbent assay for N-acetylglucosaminyltransferase-V. Analytical Biochemistry. 185(1). 112–117. 23 indexed citations
20.
Palcic, Monica M., R. Murray Ratcliffe, Louis R. Lamontagne, et al.. (1990). An enzyme-linked immunosorbent assay for the measurement of Lewis blood-group α-(1→4)-fucosyltransferase activity. Carbohydrate Research. 196. 133–140. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Kendall Breakdown of academic impact, for papers by Jenny Tan Breakdown of academic impact, for papers by Liguang Lou Breakdown of academic impact, for papers by Stephen Gately Breakdown of academic impact, for papers by Giuliana Cassinelli Breakdown of academic impact, for papers by Stefan Hart Breakdown of academic impact, for papers by Akiko Kokubu Breakdown of academic impact, for papers by Stephen Hiscox Breakdown of academic impact, for papers by Saijun Fan Breakdown of academic impact, for papers by Sabina Cosulich
Rankless by CCL
2026